Cancer immunotherapies, such as immune checkpoint inhibitors (ICIs), have revolutionized the treatment of various cancers and have shown a great efficacy in inducing antitumor immunity. Cancer immunotherapy in the form of adoptive cell transfer (ACT) have also been developed to eradicate tumor cells in a specific and effective manner, and it includes the administration of autologous tumor-infiltrating T-cells (TILs), T-cell receptor (TCR)-modified T-cells, or genetically engineered chimeric antigen receptor (CAR)-specific T-cells (CARTs) in cancer patients. Additionally, cancer vaccines and recombinant cytokines can be used as monotherapy or adjuvant therapy. Despite the success of immunotherapies in treating various solid tumors and hemato...
Cancer immunotherapies, which include chimeric antigen receptor therapy (CAR-T) and immune checkpoin...
Cancer immunotherapy can induce long lasting responses in patients with metastatic cancers of a wide...
Recent successful results with the relatively novel immunotherapeutic anti-cancer strategies such as...
The unprecedented clinical activity of checkpoint blockade in several types of cancers has formally ...
An increased understanding of the interactions between the immune system and tumors has opened the d...
Anticancer immunotherapies involving the use of immune-checkpoint inhibitors or adoptive cellular tr...
While immune checkpoint inhibitors (ICIs) have ushered in major changes in standards of care for man...
Cancer is one of the main public health problems in the world. Systemic therapies such as chemothera...
Immune checkpoint inhibitors (ICIs) are effective for various types of cancer, and their application...
Immunotherapy is a method of cancer treatment that uses the patient's immune system to attack the tu...
The development and clinical application of immune modulation represent one of the most extraordinar...
Background and significance: The rebirth of the theory of immunosurveillance in 2001 rejuvenated int...
Our immune system, fine-tuned by a long evolution, has a near-infinite capacity to recognize potenti...
Cancer is one of the leading causes of death: in the year 2007 8 million people died from cancer and...
Immune checkpoint inhibitors (ICIs) have recently revolutionized cancer treatment, providing unprece...
Cancer immunotherapies, which include chimeric antigen receptor therapy (CAR-T) and immune checkpoin...
Cancer immunotherapy can induce long lasting responses in patients with metastatic cancers of a wide...
Recent successful results with the relatively novel immunotherapeutic anti-cancer strategies such as...
The unprecedented clinical activity of checkpoint blockade in several types of cancers has formally ...
An increased understanding of the interactions between the immune system and tumors has opened the d...
Anticancer immunotherapies involving the use of immune-checkpoint inhibitors or adoptive cellular tr...
While immune checkpoint inhibitors (ICIs) have ushered in major changes in standards of care for man...
Cancer is one of the main public health problems in the world. Systemic therapies such as chemothera...
Immune checkpoint inhibitors (ICIs) are effective for various types of cancer, and their application...
Immunotherapy is a method of cancer treatment that uses the patient's immune system to attack the tu...
The development and clinical application of immune modulation represent one of the most extraordinar...
Background and significance: The rebirth of the theory of immunosurveillance in 2001 rejuvenated int...
Our immune system, fine-tuned by a long evolution, has a near-infinite capacity to recognize potenti...
Cancer is one of the leading causes of death: in the year 2007 8 million people died from cancer and...
Immune checkpoint inhibitors (ICIs) have recently revolutionized cancer treatment, providing unprece...
Cancer immunotherapies, which include chimeric antigen receptor therapy (CAR-T) and immune checkpoin...
Cancer immunotherapy can induce long lasting responses in patients with metastatic cancers of a wide...
Recent successful results with the relatively novel immunotherapeutic anti-cancer strategies such as...